ORALLY ACTIVE AND SELECTIVE ENKEPHALIN PSEUDOPEPTIDES
ORALLY ACTIVE AND SELECTIVE ENKEPHALIN PSEUDOPEPTIDES
批准号:
3210213
负责人:
ARNO F SPATOLA
金额:
$8.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1990-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Evidence has accumulated that postsynaptic serotonin (5-HT) receptors are
an important site of action for hallucinogenic drugs. Concomitantly, there
has been intensive study of 5-HT binding sites in brain and periphery.
These sites have been classified into three main groups, most commonly
referred to as 5-HT 1, 2 and 3. The 5-HT 1 sites have been further
subdivided into 5-HT 1A, 1B, 1C and 1D. The overall goal of the present
proposal is to characterize the electrophsiological actions of
hallucinogens and related drugs mediated by 5-HT receptors postsynaptic to
serotonergic raphe neurons. Hallucinogens to be tested include the ergot
D-LSD, the indoles psilocin and N,N-dimeth-yltryptamine, and the
phenylalkylamines mescaline and 2,5-dimethoxy-4-methylamphetamine. Their
actions will be compared with those of presumably non-hallucinogenic agents
including 5-HT, 5-carboxyamidotryptamine, lisuride, and 2-bromolysergic
acid diethylamide. Modulation of excitatory actions of 5-HT by
hallucinogens will also be investigated. Electrophysiological experiments
(field potential recordings and both intracellular and extracellular unit
studies) will be performed on the rat hippocampal slice in vitro. The
actions of hallucinogens will be characterized in hippocampal field CA 1
and their electrophsiological effects compared with their potency and
efficacy on the two 5-HT receptors linked to adenylate cyclase in membranes
form rat hippocampus. The inhibition of adenylate cyclase will be
assessed. LSD binds to all 5-HT 1 and 5-HT 2 sites. Regions of the
hippocampal formation exhibiting the highest densities for 5-HT 1B, 5-HT 1C
and 5-HT 2 sites will be examined to determine whether electophysiological
effects can be linked to drug action at these sites. The possible linkage
of the 5-HT 1B site to adenylate cyclase will be investigated. These
studies should yield information on some serotonergic mechanisms of action
of hallucinogens in the hippocampus and on the receptors and effectors
through which their effects are mediated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORALLY ACTIVE AND SELECTIVE ENKEPHALIN PSEUDOPEPTIDES
-
批准号:3210209
-
项目类别:
-
资助金额:$8.82万
-
财政年份:1987
-
负责人:ARNO F SPATOLA
-
依托单位:
ORALLY ACTIVE AND SELECTIVE ENKEPHALIN PSEUDOPEPTIDES
-
批准号:3210212
-
项目类别:
-
资助金额:$7.89万
-
财政年份:1987
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283042
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283044
-
项目类别:
-
资助金额:$12.0万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:2177008
-
项目类别:
-
资助金额:$14.51万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:2177009
-
项目类别:
-
资助金额:$15.1万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283041
-
项目类别:
-
资助金额:$13.96万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283040
-
项目类别:
-
资助金额:$11.91万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283045
-
项目类别:
-
资助金额:$12.35万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283047
-
项目类别:
-
资助金额:$13.26万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283039
-
项目类别:
-
资助金额:$8.49万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283046
-
项目类别:
-
资助金额:$12.75万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:2177010
-
项目类别:
-
资助金额:$15.61万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
PROPERTIES OF CONSTRAINED CYCLIC PSEUDOPEPTIDES
-
批准号:3283043
-
项目类别:
-
资助金额:$8.6万
-
财政年份:1985
-
负责人:ARNO F SPATOLA
-
依托单位:
海外基金